The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration

Toxicology Letters

Volumn 177, Issue 3, 2008, Pages 198-204

  Diel, P ^a   Friedel, A ^a   Geyer, H ^c   Kamber, M ^d   Laudenbach Leschowsky, U ^a   Schanzer W ^c   Schleipen, B ^a   Thevis, M ^c   Vollmer, G ^b   Zierau, O ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^d Federal Office of Sports   (Switzerland)

Author keywords

Anabolic steroid; Doping; Norandrostenedione; Prohormone; Skeletal muscle

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; DRUG METABOLITE; ESTR 4 ENE 3,17 DIONE; HORMONE PRECURSOR; MESSENGER RNA; MYOSTATIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TYROSINE AMINOTRANSFERASE;

ADVERSE OUTCOME; ANDROGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONE BINDING; IN VIVO STUDY; LEVATOR ANI MUSCLE; LIVER TOXICITY; MALE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; RAT; REPORTER GENE; SEMINAL VESICLE; SKELETAL MUSCLE; TRANSACTIVATION;

ANABOLIC AGENTS; ANDROSTENEDIONE; ANIMALS; INJECTIONS, SUBCUTANEOUS; LIVER; MALE; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN; TESTOSTERONE PROPIONATE;

RATTUS;

EID: 40849114433     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.01.014     Document Type: Article

References (22)

1. Boada L.D., Zumbado M., Torres S., Lopez A., Diaz-Chico B.N., Cabrera J.J., and Luzardo O.P. Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats. Arch. Toxicol. 73 8-9 (1999) 465-472
2. De Cock K.J., Delbeke F.T., Van Eenoo P., Desmet N., Roels K., and De Backer P. Detection and determination of anabolic steroids in nutritional supplements. J. Pharm. Biomed. Anal. 25 5-6 (2001) 843-852
3. Diel P., Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., Thevis M., Vollmer G., and Zierau O. Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol. Lett. 169 1 (2007) 64-71
4. Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schänzer W., Thevis M., Vollmer G., Zierau O., and Diel P. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Toxicol. Lett. 165 20 August (2) (2006) 149-155
5. Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., Thevis M., Vollmer G., Zierau O., and Diel P. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicol. Lett. 164 1 (2006) 16-23
6. Johansson M., Johansson N., and Lund B.O. Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. Basic Clin. Pharmacol. Toxicol. 96 4 (2005) 309-315
7. Jockenhövel F., Vogel E., Kreutzer M., Reinhardt W., Lederbogen S., and Reinwein D. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Clin. Endocrinol. (Oxf) 45 1 (1996) 61-71
8. Lévesque J.F., Gaudreault M., Aubin Y., and Chauret N. Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems. Steroids 70 4 (2005) 305-317
9. Marbury T., Hamill E., Bachand R., Sebree T., and Smith T. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, testim, compared to androgel. Biopharm. Drug Dispos. 24 3 (2003) 115-120
10. Matsakas A., Nikolaidis M.G., Kokalas N., Mougios V., and Diel P. Effect of voluntary exercise on the expression of IGF-I and androgen receptor in three rat skeletal muscles and on serum IGF-I and testosterone levels. Int. J. Sports Med. 25 7 (2004) 502-508
11. Matsakas A., Friedel A., Hertrampf T., and Diel P. Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat. Acta Physiol. Scand. 183 3 (2005) 299-307
12. Parr M.K., Geyer H., Reinhart U., and Schanzer W. Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. Food Addit. Contam. 21 7 (2004) 632-640
13. Schnirring L. DHEA: hype, hope not matched by facts. Phys. Sports Med. 26 (1998) 17-22
14. Schrader Y., Thevis M., and Schanzer W. Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab. Dispos. 34 8 (2006) 1328-1335
15. Sinnere D., and Bachmann M. Anabole Steroide. Das schwarze Buch (2004), BMS Verlag, Gronau
16. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 3 (1998) 327-339
17. Takahashi M., Tatsugi Y., and Kohno T. Endocrinological and pathological effects of anabolic-androgenic steroid in male rats. Endocr. J. 51 4 (2004) 425-434
18. Uralets V.P., and Gillette P.A. Over-the-counter anabolic steroids 4-androsten-3, 17-dione; 4-androsten-3beta, 17beta-diol; 19-nor-4-androstene-3, 17-dione: excretion studies in men. J. Anal. Toxicol. 23 (1999) 357-366
19. Vanderschueren D., Van Herck E., Suiker A.M., Visser W.J., Schot L.P., and Bouillon R. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 130 5 (1992) 2906-2916
20. Yamasaki K., Sawaki M., Ohta R., Okuda H., Katayama S., Yamada T., Ohta T., Kosaka T., and Owens W. OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDE. Environ. Health Perspect. 111 16 (2003) 1912-1919
21. Ziegenfuss T.N., Berardi J.M., and Lowery L.M. Effects of prohormone supplementation in humans: a review. Can. J. Appl. Physiol. 27 6 (2002) 628-646
22. Zierau O., Morrissey C., Watson R.W., Schwab P., Kolba S., Metz P., and Vollmer G. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl) naringenin and 8-prenylnaringenin. Planta Med. 69 9 (2003) 856-858